Sebastian River Holdings, Inc.'s Synerlife Heal

Sebastian River Holdings, Inc.'s Synerlife Health Corp. Enters Multi-Billion Dollar Nutraceutical Industry

Sebastian River Holdings, Inc. (OTC:SBRH), a diversified holdings company, is pleased to announce that it’s wholly-owned subsidiary, Synerlife Health Corporation, Inc., expects to launch with ready-for-market product(s) in Q2 2013, toward near-term revenues and exponential growth for Sebastian including overall increase in shareholder value.

Synerlife has entered negotiations to partner with a nutraceutical company specializing in biochemical and pharmacological features of both natural supplements and pharmaceutical drugs with formulas based on biblical principles. The company is to design and manufacture products specifically for Synerlife as proprietary formulas exclusive to the company and will be marketed by a third party to be contracted by Sebastian as CEO of Synerlife.

Currently, the primary candidate for CEO/CMO has shown strong interest in proceeding immediately to create financial and brand success for Synerlife products. As well, the company expects to finalize negotiations with both the CEO/CMO candidate and the product design expert within the next 2 weeks.

“We couldn’t be more excited about this development,” states SBRH Director, Peter Matousek. “It comes with great thanks to our funding partner in the Midwest who made the introduction for Synerlife. He feels strongly about the prospects of Synerlife toward inherent growth for Sebastian River Holdings, specifically as it relates to building shareholder value in the company moving forward.”

Synerlife Health Corporation, Inc., will specialize in Chinese herbal wellness products, powerful antioxidant formulas, effective testosterone boosters, healthy weight loss and fat burning solutions as well as health and energy beverage drinks.

More to come on this exciting venture as negotiations are finalized.

MARKET STATEMENT- NUTRACEUTICALS

According to Global Information, Inc., the global market for Nutraceuticals is projected to reach US$250 billion by 2018. Performance-wise, Nutraceuticals registered a steady growth pattern in the post- recession years. An aging population has been a major factor contributing to this growth of the nutraceuticals market.

By the year 2020, the number of individuals who are aged 60 years and above is expected to surpass 1.0 billion, with 70% of this populace dwelling in the developing nations. The nutraceuticals industry is geared to meet the rising demand for health foods and products as companies with sufficient capital for scientific research enter the nutraceuticals space.

The trend towards personalized health nutrition is expected to provide solutions to successfully prevent, manage, and treat chronic medical illnesses. Also, the availability and accessibility of healthy foods in the developing nations, evolving understanding of the concepts that promote healthy living, and the launch of targeted foods and products scientifically formulated to address disease conditions are expected to support the growth of the nutraceuticals market in the near future.